Clinical Trial Update: Sodium Tanshinone IIA Sulfonate in Left Ventricular Remodeling Secondary to Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update evaluating Sodium Tanshinone IIA Sulfonate for left ventricular remodeling following an acute myocardial infarction. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Remodeling
• Myocardial Infarction

Drugs mentioned

• Sodium Tanshinone IIA Sulfonate (Sodium tanshinone IIA sulfonate)

Snippet

Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine | Conditions: Left Ventricular Remodeling, Acute Myocardial Infarction | Phase 4 | Status: UNKNOWN